{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:46:14Z","timestamp":1768801574268,"version":"3.49.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jocd.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T23:51:05Z","timestamp":1665791465000},"page":"649-667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-9587","authenticated-orcid":false,"given":"E. Michael","family":"Lewiecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-2617","authenticated-orcid":false,"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary L.","family":"Bouxsein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan V.","family":"Bukata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Dempster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"McClung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jocd.2021.10.001","article-title":"Proceedings of the 2021 Santa Fe Bone symposium: advances in the management of osteoporosis and metabolic bone diseases","volume":"25","author":"Lewiecki","year":"2022","journal-title":"J Clin Densitom"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0002","first-page":"825","article-title":"Proceedings of the Santa Fe Bone Symposium 2006","volume":"2","author":"Lewiecki","year":"2006","journal-title":"Womens Health"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0003","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jocd.2007.12.017","article-title":"Proceedings of the eighth annual Santa Fe bone symposium, August 3-4, 2007","volume":"11","author":"Lewiecki","year":"2008","journal-title":"J Clin Densitom"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jocd.2009.02.002","article-title":"2008 Santa Fe Bone Symposium: update on osteoporosis","volume":"12","author":"Lewiecki","year":"2009","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2009.12.003","article-title":"2009 Santa Fe bone symposium","volume":"13","author":"Lewiecki","year":"2010","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2010.12.001","article-title":"Osteoporosis update from the 2010 Santa Fe bone symposium","volume":"14","author":"Lewiecki","year":"2010","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2011.11.004","article-title":"Proceedings of the 2011 Santa Fe bone symposium","volume":"15","author":"Lewiecki","year":"2012","journal-title":"J Clin Densitom"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0008","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jocd.2013.01.001","article-title":"Osteoporosis update from the 2012 Santa Fe bone symposium","volume":"16","author":"Lewiecki","year":"2013","journal-title":"J Clin Densitom"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jocd.2013.11.006","article-title":"Osteoporosis update: proceedings of the 2013 Santa Fe bone symposium","volume":"17","author":"Lewiecki","year":"2014","journal-title":"J Clin Densitom"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/07435800.2015.1005746","article-title":"Update on osteoporosis from the 2014 Santa Fe Bone Symposium","volume":"40","author":"Lewiecki","year":"2015","journal-title":"Endocr Res"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0011","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jocd.2015.11.003","article-title":"Proceedings of the 2015 Santa Fe bone symposium: clinical applications of scientific advances in osteoporosis and metabolic bone disease","volume":"19","author":"Lewiecki","year":"2016","journal-title":"J Clin Densitom"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0012","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jocd.2017.01.001","article-title":"Proceedings of the 2016 Santa Fe bone symposium: new concepts in the management of osteoporosis and metabolic bone diseases","volume":"20","author":"Lewiecki","year":"2017","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jocd.2017.10.041","article-title":"Proceedings of the 2017 Santa Fe bone symposium: insights and emerging concepts in the management of osteoporosis","volume":"21","author":"Lewiecki","year":"2018","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2018.09.010","article-title":"Proceedings of the 2018 Santa Fe bone symposium: advances in the management of osteoporosis","volume":"22","author":"Lewiecki","year":"2019","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2022.10.002_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2019.09.006","article-title":"Proceedings of the 2019 Santa Fe bone symposium: new concepts in the care of osteoporosis and rare bone diseases","volume":"23","author":"Lewiecki","year":"2019","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2022.10.002_bib0016","series-title":"Osteoporosis Foundation of New Mexico","article-title":"Highlights from the 2009 Santa Fe Bone Symposium","author":"Lewiecki","year":"2011"},{"key":"10.1016\/j.jocd.2022.10.002_bib0017","series-title":"Osteoporosis Foundation of New Mexico","article-title":"Highlights from the 2010 Santa Fe Bone Symposium","author":"Lewiecki","year":"2011"},{"key":"10.1016\/j.jocd.2022.10.002_bib0018","series-title":"Osteoporosis Foundation of New Mexico","article-title":"Highlights of the 2011 Santa Fe Bone Symposium","author":"Lewiecki","year":"2011"},{"key":"10.1016\/j.jocd.2022.10.002_bib0019","unstructured":"Lewiecki EM, Bilezikian JP, Bonewald LF, Compston JE, Heaney RP, Kiel DP, et al. 2013 Santa Fe Bone Symposium Highlights2013 9\/06\/2015. Available from: http:\/\/2013santafebonesymposium.com."},{"key":"10.1016\/j.jocd.2022.10.002_bib0020","unstructured":"Lewiecki EM, Bilezikian JP, Binkley N, Hans D, Krueger D, Marcus R, et al. 2014 Santa Fe Bone Symposium Highlights2014 9\/6\/2015. Available from: http:\/\/www.2014santafebonesymposium.com\/."},{"issue":"10169","key":"10.1016\/j.jocd.2022.10.002_bib0021","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"Am J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jocd.2022.10.002_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American association of clinical endocrinologists\/american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0024","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/00325481.2022.2069582","article-title":"The role of osteoanabolic agents in the management of patients with osteoporosis","volume":"134","author":"McClung","year":"2022","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jocd.2022.10.002_bib0026","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung","year":"2001","journal-title":"NEnglJMed"},{"key":"10.1016\/j.jocd.2022.10.002_bib0027","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","article-title":"Vitamin D3 and calcium to prevent hip fractures in elderly women","volume":"327","author":"Chapuy","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0028","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2202106","article-title":"Supplemental Vitamin D and incident fractures in midlife and older adults","volume":"387","author":"LeBoff","year":"2022","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jocd.2022.10.002_bib0029","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jocd.2022.10.002_bib0030","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jama.299.9.1036","article-title":"Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin","volume":"299","author":"Heiss","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0031","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-5122(00)00158-4","article-title":"Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study","volume":"36","author":"Mosekilde","year":"2000","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0032","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"Klibanski","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2022.10.002_bib0033","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bone.2017.05.005","article-title":"Adjusting FRAX(R) on TBS for identification of subjects at high risk of fractures","volume":"101","author":"Couraud","year":"2017","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.jocd.2022.10.002_bib0034","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1210\/jc.2018-02614","article-title":"Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implications for fracture prevention","volume":"104","author":"Mai","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jbmr.3671","article-title":"Treated osteoporosis is still osteoporosis","volume":"34","author":"Lewiecki","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2022.10.002_bib0036","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bonekey.2014.24","article-title":"Bisphosphonates and bone quality","volume":"3","author":"Pazianas","year":"2014","journal-title":"Bonekey Rep"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0037","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"Pharmacology of bisphosphonates","volume":"85","author":"Cremers","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"22","key":"10.1016\/j.jocd.2022.10.002_bib0038","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis - where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jocd.2022.10.002_bib0039","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJMclde2115900","article-title":"Continuation of bisphosphonate therapy for osteoporosis beyond 5 years","volume":"386","author":"Chang","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jocd.2022.10.002_bib0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3949\/ccjm.88a.21011","article-title":"Teriparatide: label changes and identifying patients for long-term use","volume":"88","author":"Miller","year":"2021","journal-title":"Cleve Clin J Med"},{"issue":"10","key":"10.1016\/j.jocd.2022.10.002_bib0041","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-008-0661-8","article-title":"Assessing response to osteoporosis therapy","volume":"19","author":"Lewiecki","year":"2008","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0042","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00198-018-4732-1","article-title":"Risk of subsequent fracture after prior fracture among older women","volume":"30","author":"Balasubramanian","year":"2019","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.jocd.2022.10.002_bib0043","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00198-020-05294-3","article-title":"Determinants of imminent fracture risk in postmenopausal women with osteoporosis","volume":"31","author":"Barron","year":"2020","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0044","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa048","article-title":"Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update","volume":"105","author":"Shoback","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jocd.2022.10.002_bib0045","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an endocrine society clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2022.10.002_bib0046","article-title":"The clinician's guide to prevention and treatment of osteoporosis","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0047","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jbmr.3051","article-title":"Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis","volume":"32","author":"Cosman","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"9886","key":"10.1016\/j.jocd.2022.10.002_bib0048","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0049","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2022.10.002_bib0050","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","author":"Tsourdi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0051","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11657-021-01048-8","article-title":"Prevalence of FRAX risk factors and the osteoporosis treatment gap among women >\/= 70 years of age in routine primary care across 8 countries in Europe","volume":"17","author":"McCloskey","year":"2022","journal-title":"Archives of osteoporosis"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0052","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s12603-021-1640-4","article-title":"Editorial: osteosarcopenia: a geriatric giant of the XXI century","volume":"25","author":"Duque","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jocd.2022.10.002_bib0053","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.maturitas.2020.05.012","article-title":"A clinical guide to the pathophysiology, diagnosis and treatment of osteosarcopenia","volume":"140","author":"Kirk","year":"2020","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0054","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11914-020-00602-6","article-title":"Bone-muscle mutual interactions","volume":"18","author":"Lara-Castillo","year":"2020","journal-title":"Curr Osteoporos Rep"},{"issue":"5","key":"10.1016\/j.jocd.2022.10.002_bib0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/gerona\/glq001","article-title":"Extracellular water may mask actual muscle atrophy during aging","volume":"65","author":"Yamada","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0056","doi-asserted-by":"crossref","first-page":"135","DOI":"10.14283\/jfa.2022.30","article-title":"Challenges in the development of drugs for sarcopenia and frailty - report from the international conference on frailty and sarcopenia research (ICFSR) task force","volume":"11","author":"Cesari","year":"2022","journal-title":"J Frailty Aging"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0057","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nure.12090","article-title":"Guidelines for optimizing design and analysis of clinical studies of nutrient effects","volume":"72","author":"Heaney","year":"2014","journal-title":"Nutr Rev"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0058","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.clnu.2014.04.007","article-title":"Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group","volume":"33","author":"Deutz","year":"2014","journal-title":"Clin Nutr"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0059","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/jbmr.3169","article-title":"Tethering Formation to Resorption: Reversal Revisited","volume":"32","author":"Dempster","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"983","key":"10.1016\/j.jocd.2022.10.002_bib0060","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/206489a0","article-title":"Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling","volume":"206","author":"Hattner","year":"1965","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0061","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0062","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1359\/jbmr.060314","article-title":"Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis","volume":"21","author":"Ma","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0063","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1210\/jc.2015-3698","article-title":"Effect of teriparatide on bone formation in the human femoral neck","volume":"101","author":"Cosman","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2022.10.002_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116342","article-title":"Effects of teriparatide and loading modality on modeling-based and remodeling-based bone formation in the human femoral neck","volume":"157","author":"Rooney","year":"2022","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jbmr.3309","article-title":"Remodeling- and modeling-based bone formation with teriparatide versus denosumab: a longitudinal analysis from baseline to 3 months in the AVA study","volume":"33","author":"Dempster","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0066","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/jc.2015-4181","article-title":"Differential effects of teriparatide and denosumab on intact PTH and bone formation indices: AVA osteoporosis study","volume":"101","author":"Dempster","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0067","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jbmr.4243","article-title":"Early effects of abaloparatide on bone formation and resorption indices in postmenopausal women with osteoporosis","volume":"36","author":"Dempster","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0068","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2017-02669","article-title":"Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis","volume":"103","author":"Dempster","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0069","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jbmr.4006","article-title":"Modeling-Based Bone Formation in the Human Femoral Neck in Subjects Treated With Denosumab","volume":"35","author":"Dempster","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.jocd.2022.10.002_bib0070","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jbmr.3735","article-title":"Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment","volume":"34","author":"Chavassieux","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0071","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.4457","article-title":"Modeling-Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial","volume":"37","author":"Eriksen","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.jocd.2022.10.002_bib0072","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1359\/jbmr.1997.12.8.1152","article-title":"Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis","volume":"12","author":"Dempster","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0073","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X16670154","article-title":"Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis","volume":"8","author":"Langdahl","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"10","key":"10.1016\/j.jocd.2022.10.002_bib0074","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0075","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jocd.2022.10.002_bib0076","article-title":"Epidemiology, pathophysiology and genetics of primary hyperparathyroidism","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2022.10.002_bib0077","article-title":"Classical and non-Classical Manifestations of Primary Hyperparathyroidism","author":"El-Hajj Fuleihan","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2022.10.002_bib0078","article-title":"Surgical Aspects of Primary Hyperparathyroidism","author":"Perrier","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2022.10.002_bib0079","article-title":"Task Force #8: Management of Primary Hyperparathyroidism","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2022.10.002_bib0080","article-title":"Methodology for the guidelines on evaluation and management of hypoparathyroidism and primary hyperparathyroidism","author":"Yao","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2022.10.002_bib0081","article-title":"Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.jocd.2022.10.002_bib0082","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1210\/jcem.83.8.5006","article-title":"Profile of a clinical practice: Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons","volume":"83","author":"Sosa","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2022.10.002_bib0083","unstructured":"Levey NN. 100 Million People in America Are Saddled With Health Care Debt. June 16, 2022. Access Date: September 14, 2022. Available from:https:\/\/khn.org\/news\/article\/diagnosis-debt-investigation-100-million-americans-hidden-medical-debt\/."},{"key":"10.1016\/j.jocd.2022.10.002_bib0084","series-title":"An American sickness : how healthcare became big business and how you can take it back","author":"Rosenthal","year":"2017"},{"key":"10.1016\/j.jocd.2022.10.002_bib0085","unstructured":"Becker's Healthcare. Becker's Hospital Review. Access Date: September 14, 2022. Available from:https:\/\/www.beckershospitalreview.com\/care-coordination\/17-hospitals-scaling-back-care.html?origin=BHRE&utm_source=BHRE&utm_medium=email&utm_content=newsletter&oly_enc_id=1361J3009034G8F."},{"key":"10.1016\/j.jocd.2022.10.002_bib0086","unstructured":"Tribble SJ. Buy and Bust: Collapse of Private Equity-Backed Rural Hospitals Mired Employees in Medical BillsDate Accessed: September 14, 2022. Available from:https:\/\/khn.org\/news\/article\/noble-health-private-equity-rural-hospitals-missouri-employees-medical-bills\/."},{"key":"10.1016\/j.jocd.2022.10.002_bib0087","unstructured":"Editorial Board. AZT's Inhuman Cost. 1989. Date Accessed: September 14, 2022. Available from:https:\/\/www.nytimes.com\/1989\/08\/28\/opinion\/azt-s-inhuman-cost. html#:\u223c:text=At%20%248%2C000%20a%20year%20for,do%20not%20pay%20for%20drugs."},{"key":"10.1016\/j.jocd.2022.10.002_bib0088","unstructured":"GoodRx. Duexis. Date Accessed: September 14, 2022. Available from: https:\/\/www.goodrx.com\/duexis."},{"key":"10.1016\/j.jocd.2022.10.002_bib0089","series-title":"Bill of the Month","year":"2022"},{"key":"10.1016\/j.jocd.2022.10.002_bib0090","unstructured":"CBC News. Tommy Douglas chosen as the Greatest Canadian in 2004. 2004. Date Accessed: September 14, 2022. Available from:https:\/\/www.cbc.ca\/player\/play\/1402807530#:\u223c:text=Canada's%20choice%20for%20the%20greatest,29%2C%202004%20on%20The%20National."},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0091","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00198-011-1724-9","article-title":"Prevalence of osteoporosis among cancer patients in Germany: prospective data from an oncological rehabilitation clinic","volume":"23","author":"Reuss-Borst","year":"2012","journal-title":"Osteoporos Int"},{"issue":"15","key":"10.1016\/j.jocd.2022.10.002_bib0092","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp2113128","article-title":"Cancer-Associated Hypercalcemia","volume":"386","author":"Guise","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jocd.2022.10.002_bib0093","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1200\/JOP.2016.018341","article-title":"Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors","volume":"13","author":"Stratton","year":"2017","journal-title":"J Oncol Pract"},{"issue":"9","key":"10.1016\/j.jocd.2022.10.002_bib0094","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1470-2045(08)70204-3","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy","volume":"9","author":"Gnant","year":"2008","journal-title":"Lancet Oncol"},{"issue":"9992","key":"10.1016\/j.jocd.2022.10.002_bib0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"386","author":"Gnant","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0096","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2011.2022","article-title":"Screening for osteoporosis in men receiving androgen deprivation therapy","volume":"307","author":"Alibhai","year":"2012","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jocd.2022.10.002_bib0097","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2006.07.3361","article-title":"Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer","volume":"25","author":"Michaelson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocd.2022.10.002_bib0098","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4137\/CMO.S8511","article-title":"Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab","volume":"6","author":"Lipton","year":"2012","journal-title":"Clin Med Insights Oncol"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0099","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: a population-based study","volume":"20","author":"Melton","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.jocd.2022.10.002_bib0100","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","article-title":"Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma - A randomized, double-blind, multicenter, comparative trial","volume":"98","author":"Rosen","year":"2003","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0101","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamaoncol.2019.5426","article-title":"Use of Bone-Modifying Agents Among Medicare Beneficiaries With Multiple Myeloma","volume":"6","author":"Gupta","year":"2020","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0102","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S1470-2045(20)30559-3","article-title":"Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group","volume":"22","author":"Terpos","year":"2021","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0103","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"Br J Haematol"},{"issue":"25","key":"10.1016\/j.jocd.2022.10.002_bib0104","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1182\/blood-2011-04-351437","article-title":"Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1alpha levels in patients with MGUS","volume":"118","author":"Ng","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jocd.2022.10.002_bib0105","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/jbmr.2387","article-title":"Unveiling skeletal fragility in patients diagnosed with MGUS: No longer a condition of undetermined significance?","volume":"29","author":"Drake","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2022.10.002_bib0106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000518501","article-title":"Beyond Bone Mineral Density: The Impact of Childhood Cancer and Its Treatment on Bone Structure and Strength","volume":"54","author":"Fiscaletti","year":"2021","journal-title":"Front Horm Res"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0107","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-053127","article-title":"Section On Hematology\/Oncology CSOGASOFPHO. Long-term Follow-up Care for Childhood, Adolescent, and Young Adult Cancer Survivors","volume":"148","author":"Hudson","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocd.2022.10.002_bib0108","series-title":"Orphan Drug Approval Laws","author":"Roberts","year":"2022"},{"key":"10.1016\/j.jocd.2022.10.002_bib0109","first-page":"207","article-title":"The Orphan Drug Act","volume":"127","author":"Sanders","year":"1983","journal-title":"Prog Clin Biol Res"},{"issue":"12","key":"10.1016\/j.jocd.2022.10.002_bib0110","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/ajmg.a.61366","article-title":"Nosology and classification of genetic skeletal disorders: 2019 revision","volume":"179","author":"Mortier","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0111","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s11914-020-00595-2","article-title":"The Rare Bone Disease TeleECHO Program: Leveraging Telehealth to Improve Rare Bone Disease Care","volume":"18","author":"Tosi","year":"2020","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0112","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1530\/EJE-20-0299","article-title":"Osteogenesis imperfecta: an update on clinical features and therapies","volume":"183","author":"Marom","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.jocd.2022.10.002_bib0113","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.3544","article-title":"At Long Last, an Effective Treatment for FGF23-Associated Hypophosphatemia","volume":"33","author":"Burosumab","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13023-019-1102-9","article-title":"Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium","volume":"14","author":"Javaid","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.jocd.2022.10.002_bib0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00223-019-00550-z","article-title":"Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review","volume":"104","author":"Hartley","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"10.1016\/j.jocd.2022.10.002_bib0116","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/jbmr.4130","article-title":"Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry","volume":"35","author":"Seefried","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jocd.2022.10.002_bib0117","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jbmr.3075","article-title":"Enzyme Replacement Therapy Brings New Opportunities and New Challenges","volume":"32","author":"Hypophosphatasia","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.jocd.2022.10.002_bib0118","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/jbmr.3226","article-title":"Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations","volume":"32","author":"Shapiro","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0119","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbmr.3074","article-title":"Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward","volume":"32","author":"Khosla","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00198-017-4345-0","article-title":"Hip fracture trends in the United States, 2002 to 2015","volume":"29","author":"Lewiecki","year":"2018","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jocd.2022.10.002_bib0121","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s40520-019-01294-4","volume":"31","author":"Diez-Perez","year":"2019","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jocd.2022.10.002_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115786","article-title":"Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context","volume":"143","author":"Cortet","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2022.10.002_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115297","article-title":"Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study","volume":"134","author":"Adami","year":"2020","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0124","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-8587(18)30308-5","article-title":"Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study","volume":"7","author":"Samelson","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0125","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jbmr.3901","article-title":"HR-pQCT Measures of Bone Microarchitecture Predict Fracture: Systematic Review and Meta-Analysis","volume":"35","author":"Mikolajewicz","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.jocd.2022.10.002_bib0126","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00198-021-05999-z","article-title":"The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions","volume":"32","author":"van den Bergh","year":"2021","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.jocd.2022.10.002_bib0127","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00198-020-05384-2","article-title":"Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis","volume":"31","author":"Keaveny","year":"2020","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0128","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3423","article-title":"Osteoporosis and Hip Fracture Risk From Routine Computed Tomography Scans: The Fracture, Osteoporosis, and CT Utilization Study (FOCUS)","volume":"33","author":"Adams","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0129","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2214\/AJR.20.22874","article-title":"Value-Added Opportunistic CT: Insights Into Osteoporosis and Sarcopenia","volume":"215","author":"Boutin","year":"2020","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1148\/radiol.2019181648","article-title":"Opportunistic Osteoporosis Screening at Routine Abdominal and Thoracic CT: Normative L1 Trabecular Attenuation Values in More than 20,000 Adults","volume":"291","author":"Jang","year":"2019","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1148\/radiol.2020200466","article-title":"Automated Abdominal CT Imaging Biomarkers for Opportunistic Prediction of Future Major Osteoporotic Fractures in Asymptomatic Adults","volume":"297","author":"Pickhardt","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0132","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41591-019-0720-z","article-title":"Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization","volume":"26","author":"Dagan","year":"2020","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0133","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.arth.2019.03.044","article-title":"Osteoporosis is Common and Undertreated Prior to Total Joint Arthroplasty","volume":"34","author":"Bernatz","year":"2019","journal-title":"J Arthroplasty"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0134","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2106\/JBJS.19.00999","article-title":"Bone Health Optimization in Orthopaedic Surgery","volume":"102","author":"Kadri","year":"2020","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"10.1016\/j.jocd.2022.10.002_bib0135","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00264-014-2338-6","article-title":"Is there an association between periprosthetic joint infection and low vitamin D levels?","volume":"38","author":"Maier","year":"2014","journal-title":"Int Orthop"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0136","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2020.5.FOCUS20255","article-title":"Preoperative bone health assessment and optimization in spine surgery","volume":"49","author":"Anderson","year":"2020","journal-title":"Neurosurg Focus"},{"issue":"23","key":"10.1016\/j.jocd.2022.10.002_bib0137","doi-asserted-by":"crossref","first-page":"E1464","DOI":"10.1097\/BRS.0b013e31826ca2a8","article-title":"Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study","volume":"37","author":"Ohtori","year":"2012","journal-title":"Spine (Philadelphia, PA 1976)"},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0138","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3171\/2014.5.SPINE13656","article-title":"Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis","volume":"21","author":"Inoue","year":"2014","journal-title":"J Neurosurg Spine"},{"issue":"18","key":"10.1016\/j.jocd.2022.10.002_bib0139","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"NEnglJMed"},{"key":"10.1016\/j.jocd.2022.10.002_bib0140","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.jocd.2022.10.002_bib0141","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab Treatment in Postmenopausal Women with Osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2022.10.002_bib0142","unstructured":"U.S. Department of Health and Human Services. Report to Congress: Current State of Technology-Enabled Collaborative Learning and Capacity Building Models 2019 February 2019 [cited 2022 January 14]. Available from: https:\/\/aspe.hhs.gov\/system\/files\/pdf\/260691\/ECHOAct-ConsolidatedReportToCongress.pdf."},{"issue":"3","key":"10.1016\/j.jocd.2022.10.002_bib0143","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/17446651.2022.2078304","article-title":"The current role of telehealth in the management of patients with osteoporosis","volume":"17","author":"Lewiecki","year":"2022","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.jocd.2022.10.002_bib0144","unstructured":"University of New Mexico School of Medicine. Bone Health 2021 September 25, 2021. Available from: https:\/\/hsc.unm.edu\/echo\/partner-portal\/programs\/bone-health\/."},{"issue":"1","key":"10.1016\/j.jocd.2022.10.002_bib0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00198-016-3708-2","article-title":"Telementoring: a novel approach to reducing the osteoporosis treatment gap","volume":"28","author":"Lewiecki","year":"2017","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.jocd.2022.10.002_bib0146","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1210\/js.2017-00361","article-title":"Leveraging Scarce Resources With Bone Health TeleECHO to Improve the Care of Osteoporosis","volume":"1","author":"Lewiecki","year":"2017","journal-title":"J Endocr Soc"},{"issue":"2","key":"10.1016\/j.jocd.2022.10.002_bib0147","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.rdc.2019.01.003","article-title":"Project ECHO: Telehealth to Expand Capacity to Deliver Best Practice Medical Care","volume":"45","author":"Lewiecki","year":"2019","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"10.1016\/j.jocd.2022.10.002_bib0148","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00198-022-06431-w","article-title":"Three-year progress report of Bone Health TeleECHO Moscow: a strategy to improve the care of patients with osteoporosis and other metabolic skeletal diseases in underserved communities of Russia","volume":"33","author":"Belaya","year":"2022","journal-title":"Osteoporos Int"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695022000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695022000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:45:23Z","timestamp":1761083123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695022000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":148,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1094695022000841"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2022.10.002","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc. on behalf of The International Society for Clinical Densitometry.","name":"copyright","label":"Copyright"}]}}